FDA Cancer resource on web-
NOTE TO CORRESPONDENTS Print Media: 301-827-6242
July 7, 2000 Broadcast Media: 301-827-3434
Consumer Inquiries: 888-INFO-FDA
FDA LAUNCHES ONCOLOGY TOOLS WEBSITE
CDER WEBSITE OFFERS ACCESS TO CANCER-RELATED INFORMATION
The U. S. Food and Drug Administration's Center for Drug Evaluation
and Research (CDER) internet web site has expanded its capability to provide
cancer-related information for consumers, patients, and health care
professionals. This new web page, Oncology Tools at
fda.gov, can be searched by specific types of cancer
and by approved drug therapies. This will make it easier for consumers and
patients to obtain information about different types of cancer and
treatments, as well as clinical trials and patient support groups available
to them.
Internet users can now directly access such documents as cancer drug
labeling, approval summaries, and advisory committee transcripts.
Specialized information is also available for health care professionals and
others and includes cancer-related regulatory tools, references for
performing clinical studies, and drug dose calculators.
-More-
Page 2, NTC, ONCOLOGY TOOLS WEBSITE
The Oncology Tools page was developed by the Division of Oncology
Drug Products with the support of CDER's Office of Training and
Communications in order to make the web site more user friendly to the wide
range of different groups that use it.
FDA review divisions responsible for oncology products include the
Center for Drug Evaluation and Research (CDER), the Center for Biologics
Evaluation and Research (CBER), the Center for Devices and Radiological
Health (CDRH), the Center for Food Safety and Nutrition (CFSAN) and FDA's
Office of Special Health Initiatives (OSHI). The new website includes a
link to each of the other centers. FDA's Office of Special Health Issues
(OSHI) works with cancer patients and cancer patient advocacy programs on
issues related to the FDA drug approval process, cancer clinical trials and
access to investigational therapies.
For further information about CDER's web site and this new page, please send
your comments and questions to the CDER Webmaster at webmaster@cder.fda.gov
or use the comments form provided on the web site.
####
RWR |
